Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Biopsy and Ablation of H3K27 Glioma Using Skull-Mounted Smartframe Device: Technical Case Report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Unusual Cause of Unilateral Breast Swelling

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Dural Arteriovenous Fistula of the Vein of Trolard Mimicking a Cavernous Sinus Fistula

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comparison of Frame-Based Versus Frameless Intracranial Stereotactic Biopsy: Systematic Review and Meta-Analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Long-Term Follow-Up and Predictors of Functional Outcome after Surgery for Spinal Meningiomas: A Population-Based Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk factors for need of reoperation in bilateral chronic subdural haematomas

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Clearpoint Smartframe is a magnetic resonance imaging-compatible stereotactic system often used to perform magnetic resonance imaging-guided biopsies. The system is typically mounted on the scalp through screws that pierce the skin and penetrate the outer table of the cranium. However, the frame can also be configured to be mounted directly onto the skull.

CASE DESCRIPTION: Here, we describe the clinical context well suited for a skull-mount Clearpoint Smartframe surgery. The patient suffered from a subcentimeter right parafourth ventricular contrast-enhancing lesion with hydrocephalus and underwent a right suboccipital needle biopsy followed by an occipital ventriculoperitoneal shunt. Although the hydrocephalus resolved with the ventriculoperitoneal shunt, the biopsy sample proved nondiagnostic. The patient underwent a second procedure during which the Clearpoint Smartframe was mounted onto the skull through space dissected free during the previous surgery. Diagnostic biopsy (H3K27 glioma) was performed followed by stereotactic laser ablation of the lesion.

CONCLUSIONS: We describe a case in which the skull mount Clearpoint Smartframe was used to biopsy and ablate a midline H3K27 glioma.

TidsskriftWorld Neurosurgery
Sider (fra-til)436-441
Antal sider6
StatusUdgivet - jul. 2019

Bibliografisk note

Copyright © 2019 Elsevier Inc. All rights reserved.

ID: 58984986